Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Drugs
701-720 of 1,318 results
-
-
Watch: The House Approved H.R. 3, The Pelosi Drug Bill. What Does That Mean?
KHN's Emmarie Huetteman appeared on PBS NewsHour to discuss efforts on Capitol Hill to curb the cost of prescription drugs.
-
KHN鈥檚 鈥榃hat The Health?鈥: Legislate-A-Palooza
The House passed legislation that would give federal workers 12 weeks of paid parental leave. The measure appears headed for passage in the Senate, and President Donald Trump has promised to sign the measure into law. Meanwhile, House and Senate lawmakers have a tentative deal on surprise medical bills, but don鈥檛 count on a compromise just yet. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Emmarie Huetteman of Kaiser Health News join guest host Mary Agnes Carey of KHN to discuss this and more. And for 鈥渆xtra credit,鈥 the panelists offer their favorite health stories of the week they think you should read, too.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
KHN鈥檚 鈥榃hat The Health?鈥: We Spend HOW MUCH On Health Care?
The annual accounting of national health spending is out. And the 2018 health bill for the U.S. was $3.6 trillion, consuming nearly a fifth of the nation鈥檚 economy. Meanwhile, Congress is nearing the end of the year without having finished either its annual spending bills or several other high-priority health items. Kimberly Leonard of the Washington Examiner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News join KHN鈥檚 Julie Rovner to discuss this and more. Also, Rovner interviews KHN鈥檚 Markian Hawryluk about the latest KHN-NPR 鈥淏ill of the Month.鈥
-
Pharma鈥檚 Take On The Pelosi Drug-Pricing Bill: Fair Warning Or Fearmongering?
The pharmaceutical industry鈥檚 argument that capping drug prices would compromise drug innovation stands 鈥渙n very shaky ground.鈥
-
HHS Hands Out Free HIV Prevention Drugs. Do You Qualify?
Called 鈥淩eady, Set, PrEP,鈥 the federal program will provide medication that can reduce the chances of getting AIDS to at-risk patients who don鈥檛 have insurance.
-
KHN鈥檚 鈥榃hat The Health?鈥: How鈥檚 That Open Enrollment Going?
Open enrollment for the Affordable Care Act鈥檚 marketplace plans is halfway over and, so far, the number of people signing up is down, but not dramatically. Meanwhile, Congress and President Donald Trump can鈥檛 seem to agree on what to do about teen vaping, drug prices or 鈥渟urprise鈥 medical bills. And Democrats lurch to the left on abortion. Paige Winfield Cunningham of The Washington Post, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss this and more health news.
-
This Story Contains A Warning That Might Cause Alarm 鈥 Or Apathy
Proposition 65 requires California businesses to label products and buildings with warnings about substances the state deems as toxic, ranging from aloe vera to asbestos. A state panel plans to debate whether to add acetaminophen, the active ingredient of common over-the-counter medications such as Tylenol, to the toxics list, raising questions about the value of these ubiquitous warnings.
-
New California Law May Expand Use Of HIV Prevention Drugs, With Caveats
Legislation that takes effect next July will let people buy the medications without a prescription for a limited period. Medical professionals say it鈥檚 a step in the right direction but will not significantly increase the use of the medicine without additional efforts.
-
White House Unveils Finalized Health Care Price Transparency Rule
The final directive drew swift responses from the hospital and insurance industries. The Trump administration also released a proposed rule that would require health insurers to spell out for all services beforehand just how much patients may owe for their out-of-pocket costs.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
KHN鈥檚 鈥榃hat The Health鈥: Spending Bill Slowdown
It鈥檚 November, do you know where your HHS spending bill is? Still stuck in Congress. Meanwhile, lawmakers move ahead on restricting tobacco products for youth while the administration鈥檚 proposal is MIA. Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss this and more health news from the week. Also, Rovner interviews Dan Weissmann, host of the podcast 鈥淎n Arm and a Leg.鈥
-
Voters Say Congress Needs To Curb Drug Prices, But Are Lawmakers Listening?
Nearly 8 in 10 Americans say the cost of prescription drugs is unreasonable, but the odds look grim for Congress to pass significant pricing legislation this year.
-
How Germany Averted An Opioid Crisis
Doctors are less likely to prescribe opioids in Germany and quicker to notice if a patient is at risk of abuse. And, for those who do experience addiction, treatment is easier to come by.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don鈥檛 have to.
-
Listen: HHS Files Challenge Over Rights To Gilead’s HIV-Prevention Drug
KHN's Shefali Luthra discusses the recent Trump administration lawsuit regarding the HIV-prevention drug Truvada.
-
FDA Keeps Brand-Name Drugs On A Fast Path To Market 鈥 Despite Manufacturing Concerns
The agency approved Gilead鈥檚 鈥済ame changer鈥 hepatitis C cure, bypassing concerns raised by its own federal inspectors.
-
Hospitals Take Shot At Opioid Makers Over Cost Of Treating Uninsured For Addiction
A few hundred hospitals have banded together to sue drugmakers in state courts, but far more are staying on the sidelines to avoid 'unflattering attention' about their role in the opioid crisis.
-
Moved Overseas For School, Stayed For Insulin
Katie West, an American health researcher who has lived in Germany the past three years, hasn鈥檛 mastered the language and misses her family. But not having to worry about the cost of her lifesaving medication makes it OK.